Company · CIK 0001798749 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Jade Biosciences, Inc. · JBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 AForm 4 → | Jun 26, 9:20 pm EDT | Mark EisnerDirector | 47,675 | — | — | 47,675 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:47 pm EDT | Christopher W. CainDirector | 34,843 | — | — | 34,843 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:42 pm EDT | Eric DobmeierDirector | 34,843 | — | — | 34,843 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:41 pm EDT | Lawrence Otto KleinDirector | 34,843 | — | — | 34,843 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:37 pm EDT | Erin LavelleDirector | 34,843 | — | — | 34,843 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:37 pm EDT | Fairmount Funds Management LLC +4Director, 10% Owner | 34,843 | — | — | 34,843 | — |